Spots Global Cancer Trial Database for Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
Official Title: Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
Study ID: NCT03469596
Conditions
Interventions
Study Description
Brief Summary: Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point. This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
